Amedisys: The Winning Streak Continues (AMED)
Shares of Amedisys (NASDAQ:AMED) traded at a new 52-week high today of $52.93. Approximately 162,000 shares have changed hands today, as compared to an average 30-day volume of 316,000 shares.
In the past 52 weeks, Amedisys share prices have been bracketed by a low of $24.81 and a high of $52.93 and are now at $52.35, 111% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 2.3%.
Amedisys, Inc. is a multi-regional provider of alternate-site health care services. The Company offers home health care nursing, home infusion therapy, and ambulatory surgery centers. Amedisys operates offices within a network of subsidiaries in the southern and southeastern United States.
Amedisys (NASDAQ:AMED) is currently priced 12.8% above its average consensus analyst price target of $45.67. The stock should discover initial support at its 50-day moving average (MA) of $43.56 and subsequent support at its 200-day MA of $41.05.
SmarTrend recommended that subscribers consider buying shares of Amedisys on February 16th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $36.58. Since that recommendation, shares of Amedisys have risen 42.1%. We continue to monitor AMED for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows Amedisys